UK's Oxford Biomedica confirms unsolicited bid from funds managed by EQT
14/01/2026 16:59
Jan 14 (Reuters) - British cell and gene therapy manufacturer Oxford Biomedica OXB.L confirmed on Wednesday that it has received an unsolicited cash offer from funds managed by EQT EQTAB.ST for all of its shares. (Reporting by Unnamalai L in Bengaluru; Editing by Alan Barona) ((Unnamalai.L@thomsonreuters.com))